Smith IE - Search Results

1

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.

Bonnefoi H, Smith IE, O'Brien ME, Seymour MT, Powles TJ, Allum WH, Ebbs S, Baum M. Bonnefoi H, et al. Among authors: smith ie. Br J Cancer. 1996 Feb;73(3):391-6. doi: 10.1038/bjc.1996.67. Br J Cancer. 1996. PMID: 8562348 Free PMC article. Clinical Trial.

2

Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.

Jones AL, Smith IE, O'Brien ME, Talbot D, Walsh G, Ramage F, Robertshaw H, Ashley S. Jones AL, et al. Among authors: smith ie. J Clin Oncol. 1994 Jun;12(6):1259-65. doi: 10.1200/JCO.1994.12.6.1259. J Clin Oncol. 1994. PMID: 8201387 Clinical Trial.

3

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.

O'Brien ME, Talbot DC, Smith IE. O'Brien ME, et al. Among authors: smith ie. J Clin Oncol. 1993 Nov;11(11):2112-7. doi: 10.1200/JCO.1993.11.11.2112. J Clin Oncol. 1993. PMID: 8229125 Clinical Trial.

4

Phase II trial of the novel sulphonylurea sulofenur in advanced breast cancer.

Talbot DC, Smith IE, Nicolson MC, Powles TJ, Button D, Walling J. Talbot DC, et al. Among authors: smith ie. Cancer Chemother Pharmacol. 1993;31(5):419-22. doi: 10.1007/BF00686159. Cancer Chemother Pharmacol. 1993. PMID: 8431978 Clinical Trial.

5

Chemotherapy and survival in advanced breast cancer: the inclusion of doxorubicin in Cooper type regimens.

A'Hern RP, Smith IE, Ebbs SR. A'Hern RP, et al. Among authors: smith ie. Br J Cancer. 1993 Apr;67(4):801-5. doi: 10.1038/bjc.1993.146. Br J Cancer. 1993. PMID: 8471439 Free PMC article. Clinical Trial.

6

MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.

Smith IE, Powles TJ. Smith IE, et al. Oncology. 1993 Apr;50 Suppl 1:9-15. doi: 10.1159/000227241. Oncology. 1993. PMID: 8483562 Clinical Trial.

7

Therapeutic effects of the aromatase inhibitor fadrozole hydrochloride in advanced breast cancer.

Bonnefoi HR, Smith IE, Dowsett M, Trunet PF, Houston SJ, da Luz RJ, Rubens RD, Coombes RC, Powles TJ. Bonnefoi HR, et al. Among authors: smith ie. Br J Cancer. 1996 Feb;73(4):539-42. doi: 10.1038/bjc.1996.93. Br J Cancer. 1996. PMID: 8595171 Free PMC article. Clinical Trial.

8

The prognostic implications of chemotherapy in the treatment of breast cancer.

O'Brien ME, Smith IE. O'Brien ME, et al. Among authors: smith ie. Curr Opin Obstet Gynecol. 1996 Feb;8(1):21-6. Curr Opin Obstet Gynecol. 1996. PMID: 8777253 Review.

9

How should cancer presenting as a malignant pleural effusion be managed?

Bonnefoi H, Smith IE. Bonnefoi H, et al. Among authors: smith ie. Br J Cancer. 1996 Sep;74(5):832-5. doi: 10.1038/bjc.1996.444. Br J Cancer. 1996. PMID: 8795590 Free PMC article.

10

Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer.

Seymour MT, Moskovic EC, Walsh G, Trott P, Smith IE. Seymour MT, et al. Among authors: smith ie. Br J Cancer. 1997;76(3):371-6. doi: 10.1038/bjc.1997.392. Br J Cancer. 1997. PMID: 9252205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

516 results

Search Page

Filters